| __timestamp | MorphoSys AG | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 63900978 | 1162636000 |
| Thursday, January 1, 2015 | 106145897 | 1396725000 |
| Friday, January 1, 2016 | 49646515 | 1526100000 |
| Sunday, January 1, 2017 | 66757840 | 1619600000 |
| Monday, January 1, 2018 | 74645876 | 1429100000 |
| Tuesday, January 1, 2019 | 59670105 | 1331200000 |
| Wednesday, January 1, 2020 | 318524319 | 1375200000 |
| Friday, January 1, 2021 | 147400000 | 1563000000 |
| Saturday, January 1, 2022 | 229647003 | 1789600000 |
| Sunday, January 1, 2023 | 179923313 | 2070000000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology, financial performance is a key indicator of a company's health and potential. This analysis delves into the gross profit trends of United Therapeutics Corporation and MorphoSys AG from 2014 to 2023. Over this period, United Therapeutics consistently outperformed MorphoSys AG, with gross profits peaking at approximately $2.07 billion in 2023, marking a 78% increase from 2014. In contrast, MorphoSys AG's gross profit saw a more volatile trajectory, with a notable peak in 2020 at around $318 million, a staggering 400% increase from its 2016 low. These trends highlight United Therapeutics' steady growth and MorphoSys AG's fluctuating financial journey. Investors and industry analysts can glean insights into the strategic maneuvers and market conditions influencing these companies' financial outcomes.
Key Insights on Gross Profit: Eli Lilly and Company vs MorphoSys AG
Key Insights on Gross Profit: Vertex Pharmaceuticals Incorporated vs United Therapeutics Corporation
Key Insights on Gross Profit: Teva Pharmaceutical Industries Limited vs United Therapeutics Corporation
Key Insights on Gross Profit: Biogen Inc. vs MorphoSys AG
Key Insights on Gross Profit: United Therapeutics Corporation vs Catalent, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
Annual Revenue Comparison: United Therapeutics Corporation vs MorphoSys AG
Analyzing R&D Budgets: United Therapeutics Corporation vs MorphoSys AG
Gross Profit Analysis: Comparing MorphoSys AG and Bausch Health Companies Inc.
Key Insights on Gross Profit: MorphoSys AG vs Vericel Corporation
Who Generates Higher Gross Profit? MorphoSys AG or Arrowhead Pharmaceuticals, Inc.
MorphoSys AG and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis